Hollingshead Glenn MD is categorized under Clinics in Santa Barbara, CA and active since 1997.
Hollingshead Glenn MD was established in 1997, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Glenn Hollingshead at the company’s single location by writing to 122 South Patterson Avenue # 230a, Santa Barbara, California CA 93111 or by phoning (805) 681-1733. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hollingshead Glenn MD |
| Contact Person: | Glenn Hollingshead |
| Address: | 122 South Patterson Avenue # 230a, Santa Barbara, California 93111 |
| Phone Number: | (805) 681-1733 |
| Website Address: | sansumclinic.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Hollingshead Glenn MD was started in 1997 to provide professional Clinics under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Glenn Hollingshead for inquiries that concern Hollingshead Glenn MD by calling the company number (805) 681-1733, as your correspondence is most welcome. Additionally, the physical location of the single location of Hollingshead Glenn MD can be found at the coordinates 34.443813,-119.80798 as well as the street address 122 South Patterson Avenue # 230a in Santa Barbara, California 93111.
For its online presence, you may visit Hollingshead Glenn MD’s website at sansumclinic.org and engage with its social media outlets through on Twitter and on Facebook.